Ignite Creation Date:
2025-12-24 @ 3:35 PM
Ignite Modification Date:
2026-01-05 @ 6:12 PM
Study NCT ID:
NCT00665392
Status:
COMPLETED
Last Update Posted:
2025-08-01
First Post:
2008-04-22
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Cetuximab and Combination Chemotherapy in Patients With Stage III-IV Resectable Oropharynx Cancer
Sponsor:
GERCOR - Multidisciplinary Oncology Cooperative Group
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-02-01
Start Date Type:
ACTUAL
Primary Completion Date:
2012-02-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-11-01
Completion Date Type:
ACTUAL
First Submit Date:
2008-04-22
First Submit QC Date:
None
Study First Post Date:
2008-04-23
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-12-21
Results First Submit QC Date:
None
Results First Post Date:
2021-06-25
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-07-22
Last Update Post Date:
2025-08-01
Last Update Post Date Type:
ACTUAL